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Research on preventing road traffic injuries in developing
countries is needed
Editor—The dedication of the World
Health Organization’s World Health Day
2004 to road safety is recognition of the glo-
bal threat of road traffic injuries. Increasing
population size, vehicle ownership, road
infrastructure, and transnational transporta-
tion have created a substantial public health
burden. However, little epidemiological
research has been conducted into prevent-
ing road traffic injuries in developing coun-
tries. Currently global research and develop-
ment funding per disability adjusted life year
for HIV, asthma, and blindness are $26.2,
$10.8, and $5.4, respectively, while only
$0.40 for road traffic injuries.1
Epidemiological studies of successful
interventions preventing road traffic injuries
have been conducted in developed coun-
tries.2 But to assume the same effectiveness
in developing countries is inappropriate
because of behavioural, vehicular, and
environmental differences.
A pooled analysis of street lighting inter-
vention data from developed countries
shows a protective effect,3 particularly in
pedestrian injury (relative risk 0.56), the
most common road traffic injuries in devel-
oping countries.
Annually, 1.2 million deaths are attrib-
uted to road traffic crashes, 85% occurring
in developing countries.4 If an intervention
such as street lighting could reduce deaths
by as much as 30%, there is a potential to
save thousands of lives.
Various international aid agencies are
investing in road infrastructure develop-
ment. These initiatives could be coupled
with the need to develop concrete epide-
miological data. Innovative strategies, such
as step wedge study design,5 could lead to
the evolution of an evidence based public
health approach to this problem.
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Alcohol limit for drink driving
should be much lower
Editor—For more than a century alcohol
has been recognised as one of the principal
risk factors for motor vehicle crashes.1
Nearly half of the roughly 35 000 fatal
motor vehicle crashes in the United States
each year are alcohol related, meaning that
someone in the crash, usually a driver, is
intoxicated.
Currently, a blood alcohol concentration
ranging from 0.08 to 0.10 mg per 100 ml
constitutes prima facie evidence in most
countries for driving under the influence of
alcohol. In the United Kingdom, United
States, Canada, South Africa, and Sri Lanka
the legal limit is 0.08 mg per 100 ml, which
is too high as driving skills deteriorate and
the risk of becoming involved in a crash risk
increases from a concentration of 0.02 mg
per 100 ml. In their comprehensive review
Zador et al estimated that a driver’s risk of
being in a fatal crash increased significantly
from 0.02 mg per 100 ml.2 Scientific data
provide clear evidence that important
driving skills are impaired at very low blood
alcohol concentrations.
Because the legal blood alcohol concen-
tration in most countries is so high, people
often mistakenly believe that they may drive
up to a blood alcohol concentration of 0.8mg
per 100 ml, overlooking the fact that driving
is impaired at lower concentrations. To set a
blood alcohol limit so high that a 72 kg man
can drink four bottles of beer and still be
under the legal limit has consequences. It may
adversely influence people’s estimates of their
relative risk of injury or death while driving.
Drinking and driving policies and decisions
about enforcement need to be hinged on the
scientific evidence.3
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Lithium and motor vehicle
crashes
Perhaps bipolar disorder is the risk, not
its treatment
Editor—Etminan et al found that elderly
people taking lithium had approximately
double the rate of motor vehicle crashes
compared with controls.1 They imply that
lithium is responsible and say that patients
must be told of the increased risk. However,
both the inference and the advice are
unwarranted and unhelpful since lithium is
simply a proxy for having bipolar disorder.
As no information is given about the
relative risk of having a crash in the presence
of bipolar disorder, it cannot be justified to
warn patients against taking lithium if they
have this condition. It is quite possible—
indeed clinical judgment would suggest—
that a patient with bipolar disorder may be a
much safer driver when taking a mood
stabilising agent than when he or she is not.
The authors include a comparison with
carbamazepine, presumably to show that the
increased risk is restricted to lithium. This
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